Works in Rheumatology & Therapy, 2021, Vol 8, Issue 2


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.

    Published in:
    Rheumatology & Therapy, 2021, v. 8, n. 2, p. 903, doi. 10.1007/s40744-021-00305-z
    By:
    • Mease, Philip J.;
    • Lertratanakul, Apinya;
    • Papp, Kim A.;
    • van den Bosch, Filip E.;
    • Tsuji, Shigeyoshi;
    • Dokoupilova, Eva;
    • Keiserman, Mauro W.;
    • Bu, Xianwei;
    • Chen, Liang;
    • McCaskill, Reva M.;
    • Zueger, Patrick;
    • McDearmon-Blondell, Erin L.;
    • Pangan, Aileen L.;
    • Tillett, William
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29